UK launches third dose vaccine study

The British government on Wednesday conducted clinical trials based on the immune response received by the third dose of the anti-Govt vaccine for a commemorative campaign in the UK where Indian diversity is advancing.

• read more: London believes in the effectiveness of Indian variant vaccines

• read more: The UK is easing health restrictions

The most devastated country in Europe with nearly 128,000 deaths, the United Kingdom has significantly improved its health condition after a long and severe winter imprisonment and massive vaccination campaign.

Authorities plan to launch a booster campaign in the fall, following clinical trials of the immune response obtained with the third dose of the vaccine to protect the progress made.

This Public Health Service (NHS) study, which includes 2,886 fully vaccinated volunteers, will examine the effects of seven different vaccines: Oxford / Astrogenega, Pfizer / Bioendech, Moderna, NovaVox, Volneva, Johnson and Kurevac.

Funding of 19 19.3 million ($ 33 ​​million) from the government, which will begin in June, is expected to be the first results in September.

The government hopes to stay ahead of the epidemic through vaccination. This is because, with hotels, cultural venues and stadiums reopening on Monday, the rapid progress of the diversity initially identified in India is worrying, even as the country continues its restructuring.

According to Health Minister Matt Hancock, 2,967 cases related to the highly contagious B1.617.2 variant have so far risen by about 33% in the UK, particularly in the UK and northwest London, since Monday.

The government has been accused of delaying strict restrictions on travel from India in April when Prime Minister Boris Johnson was planning a trip to New Delhi.

See also  The United States wants to go further, while other countries refuse the deal

This official visit was finally canceled in the face of new pollution in India, which was finally added to the UK’s “red list”. Travelers arriving from these locations must complete the hotel isolation at their own expense at a cost of 1, 1,750 (approximately 99,995).

To prevent the spread of the Indian variant, the government is counting on mass screening and acceleration of the vaccination program, which has already made it possible for 70% of adults to receive first aid and 40% of them to be vaccinated, or nearly 21 million people.

“We also believe that these vaccines work against Indian diversity,” Matt Hancock assured at a news conference. “This means that our strategy is right: to carefully change the restrictions on our freedoms with the protection provided by vaccines.”

Criticized by Labor opposition for its lack of clarity on international travel restrictions and re-approved since Monday, Boris Johnson on Wednesday advised against traveling to countries that are not on the UK Green List.

“You should not go to the Amber List country except in extreme situations like the serious illness of someone in your family,” he said during the weekly session. Questions to the government.

The latter has set up a system that categorizes countries into three lists (green, orange and red) according to the health status of the site, to avoid importing types.

The ministers, who have been questioned by various media in recent days, have expressed different views on whether or not to go for the places on the orange list, causing confusion.

See also  London summons Myanmar ambassador to Britain to demand immediate "immediate release" of Aung San Suu Kyi

The most popular destinations for UK holiday makers, such as Spain, Italy, France and Greece, are on the Orange List, forcing travelers from those countries to spend ten days in isolation at home and to endure two screenings for a fee.

Only a few of them, like Portugal, are placed on the ‘green list’, which allows them to avoid an isolation during the holidays and to perform only one Govt-19 test when they return.

Matt Hancock also announced a face-to-face meeting of G7 health ministers in Oxford on June 3-4 to discuss global health care.

Leave a Reply

Your email address will not be published. Required fields are marked *